Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
antihemophilic factor, human recombinant | asialoglycoprotein receptor 2 | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | binder |
antihemophilic factor, human recombinant | calreticulin | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | chaperone |
antihemophilic factor, human recombinant | calnexin | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | chaperone |
antihemophilic factor, human recombinant | coagulation factor x | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | activator |
antihemophilic factor, human recombinant | coagulation factor ix | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | cofactor |
antihemophilic factor, human recombinant | 78 kda glucose-regulated protein | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | chaperone |
antihemophilic factor, human recombinant | protein ergic-53 | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | chaperone |
antihemophilic factor, human recombinant | prolow-density lipoprotein receptor-related protein 1 | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | modulator |
antihemophilic factor, human recombinant | multiple coagulation factor deficiency protein 2 | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | modulator |
antihemophilic factor, human recombinant | phytanoyl-coa dioxygenase, peroxisomal | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | antagonist |
antihemophilic factor, human recombinant | von willebrand factor | biotech | NA | drugbank | Factor XIII Deficiency[MeSHID:D005177] von Willebrand Disease[MeSHID:D014842] Hemophilia A[MeSHID:D006467] |
NA | approved,investigational | binder |
click here to return to the previous page |